Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19

Detalles Bibliográficos
Autores principales: ŞEN, Nesrin, TEZCAN, Mehmet Engin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140880/
https://www.ncbi.nlm.nih.gov/pubmed/34046582
http://dx.doi.org/10.46497/ArchRheumatol.2021.8228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140880/
https://www.ncbi.nlm.nih.gov/pubmed/34046582
http://dx.doi.org/10.46497/ArchRheumatol.2021.8228

Ejemplares similares